Resources

FOR ADULT PATIENTS.
It is not known if ONUREG® is safe and effective in children under 18 years of age.

Helpful resources for people with AML

This calendar can help you remember when to take your ONUREG® dose MAKE YOUR custom CALENDAR

Here are some additional links that may provide more resources

Bristol Myers Squibb takes no responsibility for the content of these resources.

Important questions to ask your healthcare team

Always try to talk openly with your healthcare team. Asking questions can help you make informed choices about your care. The following questions are just examples. As your care providers give you answers, consider taking notes, so you can review the information later.

Questions about AML treatment with ONUREG®
Why is ONUREG® right for me?
What are the most important things I need to know about ONUREG®?
What should I expect while taking ONUREG®?
Are there side effects that I should watch out for?
Is there something you could give me if I experience nausea, vomiting, or diarrhea?
Are there things that I should not do while taking ONUREG®?
Where and how do I take ONUREG®?
How often should I come in for follow-up visits or bloodwork while taking ONUREG®?
How long will it take for ONUREG® to start working? How will I know if it’s working?

Glossary

The medical details of AML treatment can seem complex. The following list of definitions may be helpful to you—and to the caregivers, friends, and family who are supporting you.

Acute: An illness that will progress quickly if left untreated

Blasts: Young, immature cells that build up in the bone marrow. They are unable to fight infections the way healthy, mature white blood cells can. Also known as myeloblasts

Bone marrow: The soft interior of the bones where new blood cells are created

Bone marrow transplant: A type of transplant that involves transferring healthy stem cells from a donor to a person with AML. This treatment is also known as a stem cell transplant or a hematopoietic stem cell transplant

Complete remission/remission: The absence of signs and symptoms of AML

Consolidation therapy: Additional chemotherapy treatment that may be given after induction. Consolidation therapy consists of similar drugs used during induction, however, at different doses

Continued treatment: Medication used in a person with AML in first remission, after the first phase of cancer treatment, over an extended period of time

Intensive induction therapy: The first phase of treatment a person with AML receives. This treatment is usually the strongest against blast cells

Neutropenia: A low number of neutrophils (a type of white blood cell)

Placebo: An inactive substance that has no therapeutic effect but may be used to compare the effects of an active drug

Platelets: Help prevent bleeding caused by cuts and bruises (help with blood clotting)

Post-remission treatment: Treatment that is given to continue to keep a person with AML in remission and can help prevent AML from returning

Red blood cells: Carry oxygen from the lungs to all cells in the body

Stem cell transplant: See “Bone marrow transplant”

Thrombocytopenia: A low number of platelets

White blood cells: Help the body fight infections. They are a crucial part of the body’s immune system